NanoString Blog

Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease affecting people who have suffered repeated concussions and traumatic brain injuries (TBI). CTE was first described in 1928 by Dr. Harrison…

What is Multiple Sclerosis? In 1868, a German physician Leopold Ordenstein and his mentor Jean-Martin Charcot, published a work that fundamentally changed our understanding of the disease Multiple Sclerosis1. For…

The T cell receptor (TCR) is one of the distinguishing molecules of the adaptive immune system. TCRs allow mammalian immune systems to recognize and respond to foreign entities (pathogens, vaccines,…

Vaccines: biological agents eliciting an immune response to a specific antigen derived from an infectious disease-causing pathogen. The concept of a “vaccine” emerged in 1796 when Edward Jenner developed the…

Normally, the months of September and October are dotted with important dates—end of summer barbeques, the first day of school, joyful plans for Halloween and excitement for the upcoming Holiday…

Exploration is in our DNA. As Homo Sapiens developed in the habitable regions of Africa, search of new food sources, climate changes, and mere curiosity pushed us beyond our confines…

“Analysis of pulmonary vessels showed that widespread thrombosis with microangiopathy ─ a severe condition wherein small blood clots are formed within the tiniest of blood vessels ─ was 9x more…

Cancer immunotherapy (CIT) research and investments have progressed in the past few years thanks to its successful application across a…

2018 was an incredibly productive year for scientific publications showcasing the NanoString platform and assays. We added nearly 500 publications of various scientific disciplines which are available on our website here.…

What do we already know about tumor-immune system interactions, and how can this information be used to help guide us toward the best therapeutic choice? That is exactly the question…